DyNAbind
Dresden · Founded 2017
About DyNAbind
DyNAbind is a privately-held biotech company from Dresden offering partnerships and solutions for better drug discovery with Dynamic DNA-Encoded Library (D-DEL) technologies. We have overhauled the DEL discovery process by introducing proprietary innovations in library design, selection and validation, all of which lead to a faster path to high-quality, relevant starting points for medicinal chemistry – and the only DEL platform on the market fully designed to integrate with a fragment-based discovery methodology.
Company Facts
- Founded: 2017
- Legal name: DyNAbind GmbH
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (May 2019)
- Website: dynabind.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/dynabind-8421740 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.